Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Eledon Pharmaceuticals, Inc.
Market Cap
$189.50M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$191.67M
Net Profit Margin
-36.80%
TTM Avg
-24.29%
3Y Avg
-59.84%
5Y Avg
-44.50%
Market Cap
$192.84M
Net Profit Margin
0.00%
TTM Avg
-122.98%
3Y Avg
-61.49%
5Y Avg
-40.99%
Market Cap
$184.04M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$183.17M
Net Profit Margin
-6559.27%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$180.99M
Net Profit Margin
0.00%
TTM Avg
-2904.41%
3Y Avg
-1452.20%
5Y Avg
-968.14%
Market Cap
$180.89M
Net Profit Margin
3202.50%
TTM Avg
1601.25%
3Y Avg
554.42%
5Y Avg
279.00%
Market Cap
$178.83M
Net Profit Margin
-3881.54%
TTM Avg
-6298.52%
3Y Avg
-6043.31%
5Y Avg
-5544.50%
Market Cap
$199.57M
Net Profit Margin
-2885.33%
TTM Avg
-3778.66%
3Y Avg
-1961.34%
5Y Avg
-1307.56%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | $189.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| RxSight, Inc. (RXST)vs › | $191.67M | -36.80% | -24.29% | -59.84% | -44.50% |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $192.84M | 0.00% | -122.98% | -61.49% | -40.99% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $184.04M | 0.00% | 0.00% | 0.00% | 0.00% |
| Canton Strategic Holdings Inc (CNTN)vs › | $183.17M | -6559.27% | 0.00% | 0.00% | 0.00% |
| Compass Therapeutics, Inc. (CMPX)vs › | $180.99M | 0.00% | -2904.41% | -1452.20% | -968.14% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $180.89M | 3202.50% | 1601.25% | 554.42% | 279.00% |
| Yarrow Bioscience Inc (YARW)vs › | $178.83M | -3881.54% | -6298.52% | -6043.31% | -5544.50% |
| Surrozen, Inc. (SRZN)vs › | $199.57M | -2885.33% | -3778.66% | -1961.34% | -1307.56% |
| Alector, Inc. (ALEC)vs › | $201.70M | -850.13% | -398.77% | -257.91% | -325.14% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
